DeepMed Research

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.eortc.be

Clinical Trials

BCG With or Without Mitomycin in Treating Patients With Bladder Cancer

Phase 2

Completed

Conditions: Bladder Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 97

Registration Number: NCT00023842

Locations: 🇧🇪
Virga Jesse Hospital, Hasselt, Belgium
🇧🇪
Universitair Ziekenhuis Gent, Ghent, Belgium
🇮🇹
Ospedale di Circolo e Fondazione Macchi, Varese, Italy

and more 13 locations

Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva

Phase 2

Completed

Conditions: Vulvar Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 31

Registration Number: NCT00014599

Locations: 🇳🇱
University Medical Center Nijmegen, Nijmegen, Netherlands
🇮🇹
Ospedale di Circolo e Fondazione Macchi, Varese, Italy
🇮🇹
Ospedale Mauriziano Umberto I, Torino, Italy

and more 11 locations

Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer

Phase 3

Terminated

Conditions: Ovarian Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 38

Registration Number: NCT00006356

Locations: 🇮🇹
Spedali Civili, Brescia, Italy

Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

Phase 2

Completed

Conditions: Sarcoma

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 48

Registration Number: NCT00052754

Locations: 🇧🇪
U.Z. Gasthuisberg, Leuven, Belgium
🇫🇷
Centre Antoine Lacassagne, Nice, France
🇫🇷
Centre Leon Berard, Lyon, France

and more 13 locations

Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 21

Registration Number: NCT00017498

Locations: 🇧🇪
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
🇧🇪
U.Z. Gasthuisberg, Leuven, Belgium
🇮🇹
Ospedale Santa Croce, Cuneo, Italy

and more 4 locations

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

Phase 2

Terminated

Conditions: Drug/Agent Toxicity by Tissue/Organ
Head and Neck Cancer
Oral Complications
Radiation Toxicity

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 5

Registration Number: NCT00025298

Locations: 🇮🇹
Ospedale Santa Croce, Cuneo, Italy
🇧🇪
U.Z. Gasthuisberg, Leuven, Belgium
🇮🇹
Istituto Nazionale per lo Studio e la Cura dei Tumori, Naples, Italy

and more 9 locations

Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 32

Registration Number: NCT00039351

Locations: 🇳🇱
Academisch Ziekenhuis Groningen, Groningen, Netherlands
🇧🇪
Ziekenhuis Network Antwerpen Middelheim, Antwerp, Belgium
🇧🇪
Centre Hospitalier Universitaire Brugmann, Brussels, Belgium

and more 14 locations

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer

Phase 3

Terminated

Conditions: Bladder Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 58

Registration Number: NCT00042887

Locations: 🇧🇪
Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels, Belgium
🇧🇪
Universitair Ziekenhuis Gent, Ghent, Belgium
🇧🇪
Virga Jesse Hospital, Hasselt, Belgium

and more 9 locations

Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer

Phase 3

Terminated

Conditions: Head and Neck Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 47

Registration Number: NCT00017277

Locations: 🇧🇪
Institut Jules Bordet, Brussels (Bruxelles), Belgium
🇫🇷
Institut Gustave Roussy, Villejuif, France
🇮🇱
Rambam Medical Center, Haifa, Israel

and more 12 locations

SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract

Phase 2

Completed

Conditions: Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
Urethral Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 34

Registration Number: NCT00006351

Locations: 🇳🇱
University Medical Center Nijmegen, Nijmegen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy